Farther Finance Advisors’s ArriVent BioPharma AVBP Stock Holding History

Farther Finance Advisors’s Portfolio AVBP Stock Details AVBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$16K	Sell	528 -103	-16%	-$3.15K	﹤0.01%	4322
2026 Q2	$21.7K	Sell	631 -40	-6%	-$1.18K	﹤0.01%	3911
2026 Q1	$16.3K	Buy	671 +336	+100%	+$7.59K	﹤0.01%	3793
2025 Q4	$6.74K	Buy	+335	New	+$6.97K	﹤0.01%	4157

Other funds holding AVBP

VCM

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

MPWT

MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

Farther Finance Advisors's AVBP Position: Q3 2026 in Review

Farther Finance Advisors reduced its ArriVent BioPharma (AVBP) stake by 16% in Q3 2026, selling an estimated $3.15K and leaving 528 shares worth $16K. The position accounts for ﹤0.01% of the portfolio, ranked #4322.

Farther Finance Advisors first reported a position in AVBP in Q4 2025 and has held it in 4 quarters since. The position peaked at $21.7K in Q2 2026. 4 funds tracked by Wall St. Rank hold AVBP as of Q3 2026.

Farther Finance Advisors held 528 shares of ArriVent BioPharma worth $16K as of Q3 2026.
Farther Finance Advisors sold 103 ArriVent BioPharma shares in Q3 2026, an estimated $3.15K.
ArriVent BioPharma made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #4322 holding.
Farther Finance Advisors first reported a position in ArriVent BioPharma in Q4 2025 and has held it in 4 quarters since.
Farther Finance Advisors's ArriVent BioPharma position peaked at $21.7K in Q2 2026.
4 funds tracked by Wall St. Rank held ArriVent BioPharma as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.